Printer Friendly
The Free Library
14,758,148 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Rohto Pharmaceutical to Acquire Bayer Yakuhin's Research Center in Kyoto.


Tokyo, Japan, Aug 4, 2005 - (JCNN JCNN Japan Corporate News Network ) - Rohto Pharmaceutical announced on August 2 that it signed a contract with Bayer Yakuhin for the acquisition of a research center as of July 20.

Under the terms of the contract, Rohto Pharmaceutical has acquired Bayer Yakuhin Research Center Kyoto located in Kizu-cho.

Taking this opportunity, Rohto Pharmaceutical aims to strengthen its operations in the fields of functional cosmetics cosmetics, preparations externally applied to change or enhance the beauty of skin, hair, nails, lips, and eyes. The use of body paint for ornamental and religious purposes has been common among primitive peoples from prehistoric times (see body-marking).  and food products by promoting collaboration Working together on a project. See collaborative software.  with venture companies as well as researchers in Japan and overseas.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Geographic Code:9JAPA
Date:Aug 4, 2005
Words:98
Previous Article:Tsumura, Dainippon Pharmaceutical to Cease Development of Lercanidipine Hydrochloride, Hypertension Drug Candidate.
Next Article:Sawai Pharmaceutical to Take over Three Ethical Products from Nihon Schering.



Related Articles
Bayer Corporation.(Worldwatch)
Rohto Pharmaceutical Joins Hands with Pharma Foods International.
Shionogi Launches New Quinolone Antibacterial "Avelox(R) Tablet 400mg" (Moxifloxacin Hydrochloride).
Bayer Yakuhin Begins Providing Pollen Dispersal Information.
Nagase, Others Find that Seaweed Polyphenol Detoxifies Intestines.
Bayer Yakuhin to Transfer Baynas Marketing Rights to Nippon Shinyaku.
Rohto Pharmaceutical Sets Up New Research Base in Kyoto.
Rohto Pharmaceutical, Dynamics Therapeutics Enter into Licensing Agreement for Anti-aging Ingredient Supplamine.
Bayer Yakuhin Files Anti-cancer Drug Nexavar(R) for the Treatment of Advanced Renal Cell Carcinoma.
Bayer Yakuhin Ltd. has Filed Fosrenol(R) for the Treatment of Hyperphosphatemia in Japan.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles